ランキング価格はじめての方へ
  1. 米国企業
  2. MEI Pharma, Inc.

MEI Pharma, Inc.MEIP

時価総額
$1872.3万
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2012年
6月30日		2013年
6月30日		2014年
6月30日		2015年
6月30日		2016年
6月30日		2017年
6月30日		2018年
6月30日		2019年
6月30日		2020年
6月30日		2021年
6月30日		2022年
6月30日		2023年
6月30日
Net loss-8-11-----40-17-46-51-54-32
Change in fair value of warrant liability-------1028-2318212
Share-based compensation3454323771084
Non-cash lease expense----------11
Issuance of warrants-----------1
Depreciation and amortization-00000000000
Non-cash lease expense----------11
Impairment of intangible assets--------0---
Depreciation and amortization-00000000000
Unbilled Receivables----------2-10
Receivable for foreign tax withholding---------2020--
Prepaid expenses and other current assets000001-013103
Prepaid expenses and other current assets000001-013103
Accounts payable111-10-031-242-2
Accounts payable111-10-031-242-2
Accrued liabilities11210-1011222
Accrued liabilities11210-1011222
Deferred revenue-------775516-31
Deferred revenue-------775516-31
Operating lease liability---------1-1-1
Operating lease liability---------1-1-1
Net cash used in operating activities-7-10-----21-2934-32-49-52
Purchases of property and equipment000000-01100
Purchases of short-term investments--3570556011465190420273102
Proceeds from maturity of short-term investments---606550708985446280155
Net cash provided by investing activities-0-0-----4424-10625754
Proceeds from Issuance of Common Stock871263343-4----52-
Payment of issuance costs----------4-
Proceeds from Stock Options Exercised------00001-
Payments of tax withholdings related to vesting of restricted stock units-------0--00
Proceeds From Previously Issued Common Stock--------5---
Net cash (used in) provided by financing activities87127----70175349-0
Net cash (used in) provided by financing activities87127----70175349-0
Net increase in cash and cash equivalents--------3-471
Income taxes paid-0-0-0-0-0-0-0-0-0-0--
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability---------924
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability---------924
Warrants issued pursuant to cashless exercise---------0--